Neuroinflammation
Neuroinflammation is an inflammatory process involving the nervous system and is studied in relation to interactions among microglia, astrocytes, neurons, and inflammatory signaling.
Neuroinflammation is an inflammatory process involving the nervous system and is studied in relation to interactions among microglia, astrocytes, neurons, and inflammatory signaling. The provided literature connects it with proinflammatory cytokines such as interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), oxidative stress, reactive oxygen species, NLRP3 inflammasome activation, apoptosis, and changes in neuronal function. These processes are examined in conditions including Parkinson’s disease, epilepsy, ischemic and hypoxic–ischemic brain injury, hepatic and diabetic encephalopathy, insomnia, cognitive impairment, and sensory hypersensitivity.
In the cited studies, neuroinflammation serves both as a biological process associated with tissue injury and as a therapeutic target. Investigational approaches include plant-derived compounds and traditional formulations, metabolic and signaling modulators such as apelin-13 and AMPK-related interventions, microbiota and tryptophan-metabolism regulation, mitochondrial-targeted compounds, extracellular-vesicle drug delivery, antimicrobial-releasing neural implants, and combinations directed at inflammatory pathways. The recent work extends the literature’s emphasis on oxidative stress and microglial activation, inflammation-linked cognitive dysfunction, and drug delivery for brain inflammation.
Rebuilt from PubMed 18 Sept 2026 · no new papers today
Where the papers sit
11 papers study neuroinflammation directly. The themes below are drawn from those 11.
-
Oxidative Stress and Mitochondrial Dysfunction : Antioxidant and mitochondrial strategies are being paired with GABAergic, inflammasome and gut-microbiota modulation across epilepsy and Parkinson disease models. Oxidative stress, glutamate imbalance and microglial or astrocyte activation recur as therapeutic targets. 4 papers · 36.4%
-
Cytokine-Linked Cognitive and Neurological Injury : Cytokine suppression is being linked to recovery from cognitive and neurological injury through ERK/MAPK, tau, chemokine-receptor, AMPK/SIRT1 and adenosine pathways. Hesperidin, Wumei Pill, Tianwang Buxin Decoction and Apelin-13 consistently reduce inflammatory damage while improving behavioral or neurological outcomes. 4 papers · 36.4%
-
Drug Delivery Across the BBB : Neuroinflammatory therapy is moving toward localized or biologically derived delivery, including antimicrobial-releasing intracortical probes and milk-derived extracellular vesicles. Blood–brain barrier access, drug accumulation and hepatic encephalopathy recur as practical targets. 3 papers · 27.3%
Recent Findings on Neuroinflammation
Parkinson’s disease, gut microbiota, and tryptophan metabolism: A study of Lycium ruthenicum Murray anthocyanins investigated their ability to alleviate neuroinflammation in an MPTP-induced mouse model of Parkinson’s disease. The work linked the intervention to modulation of gut microbiota and tryptophan metabolism, extending the oxidative-stress and microglia-centered research theme toward gut–brain metabolic regulation 42322853Jun.
Hypoxic–ischemic brain injury: Apelin-13 was investigated in neonatal rats with hypoxic–ischemic encephalopathy to assess anti-inflammatory effects and mechanisms involving AMPK activation. The study reported attenuation of neuroinflammation together with improved neurological function, placing AMPK signaling within the literature on cytokine-associated neuronal injury 42341638Jun.
Insomnia and adenosine–AMPK/SIRT1 signaling: Tianwang Buxin Decoction was evaluated for its effects on insomnia and neuroinflammation. The stated mechanism involved adenosine accumulation and the AMPK/SIRT1 pathway, linking a traditional formulation to metabolic regulation of inflammatory responses 42069163May.
Diabetic encephalopathy and astrocyte-derived chemokines: Wumei Pill was studied in diabetic encephalopathy, with emphasis on whether its neuroprotective effects involved CXCL1/CXCR2 signaling-mediated neuroinflammation. The work specifically examined astrocyte-derived chemokine signaling in relation to cognitive dysfunction and inflammatory injury 42106017May.
Mitochondrial dysfunction and ischemic stroke: Researchers designed and biologically evaluated a multi-layer-linked idebenone derivative intended to target both mitochondrial dysfunction and neuroinflammation in ischemic stroke. This study connects mitochondrial mechanisms with inflammatory injury and extends the oxidative-stress and mitochondria-oriented direction of neuroinflammation research 42314599Jun.
Extracellular-vesicle delivery for neuroinflammatory disease: Milk-derived extracellular vesicles (mEVs) were investigated as an oral drug-delivery system for ellagic acid and interferon-β (IFN-β). The compounds were encapsulated in mEVs and evaluated in experimental autoimmune encephalomyelitis and lipopolysaccharide-induced neuroinflammation models, addressing the stability and bioavailability of ellagic acid while testing a delivery strategy for neuroinflammatory disease 42690904Sep.
Inflammasome-associated neuroinflammation in epilepsy: Morin, a bioflavonoid found in Morus alba, was studied in drug-resistant epilepsy. The research examined its modulation of neuroinflammatory pathways, particularly inflammasome-associated mechanisms, in the context of seizures and inflammation 42607854Aug.
Hepatic encephalopathy and NLRP3 activation: A combination of berberine and lactulose was evaluated in rats with thioacetamide-induced hepatic encephalopathy. The study addressed neuroinflammation and hepatic injury, building on the reported association of berberine treatment with reduced neuroinflammation and NLRP3 inflammasome activation 42616213Aug.
Toxic cognitive impairment, ERK/MAPK signaling, and microglia: Hesperidin was investigated in mice exposed to aluminum chloride. The study assessed cognitive impairment together with ERK/MAPK signaling, tau protein immunoexpression, neuroinflammation, and microglial activation, using these measures to examine the compound’s neuroprotective effects 42611390Aug.
Spatially resolved modulation around intracortical probes: A therapeutic-releasing intracortical probe platform was examined using spatial proteomic analysis. The work used the controlled-release capacity of therapeutic-loaded materials to mitigate neuroinflammation at the implantation site and to characterize specific neuroinflammatory pathways, extending drug-delivery research to implanted neural devices 42504606Jul.
GABAergic modulation and auditory hypersensitivity: In male mice treated with sodium salicylate, researchers investigated auditory hypersensitivity in relation to neuroinflammation, microglial activation, and neuronal excitability. GABAergic modulation was reported to alleviate both auditory hypersensitivity and neuroinflammation, linking inhibitory neurotransmission with inflammatory and neuronal responses 42086103May.
Overall research direction: Collectively, these publications extend three prominent lines of investigation: oxidative stress and microglial activation in neurological disease; inflammation-linked cognitive and functional impairment involving astrocytes, cytokines, neurons, and signaling pathways such as AMPK, SIRT1, and ERK/MAPK; and targeted delivery approaches for neuroinflammatory conditions. They also introduce or reinforce connections among neuroinflammation, gut microbiota, tryptophan metabolism, mitochondrial dysfunction, NLRP3 signaling, inflammasome activity, extracellular-vesicle delivery, and neural-implant interfaces.
Written from 11 PubMed abstracts, each one cited by PMID above. Published: 2026-09-16. Drafted by language models from published abstracts; not medical advice.